Shanghai Shenqi Pharmaceutical Investment Management Co Ltd
SSE:600613

Watchlist Manager
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd Logo
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd
SSE:600613
Watchlist
Price: 6.27 CNY -0.48% Market Closed
Market Cap: ¥3.3B

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd
Investor Relations

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. engages in the research and development, manufacture, and sale of antitumor, cardiovascular, cold and cough, children medicine, and anti fungi drugs. The company is headquartered in Shanghai, Shanghai and currently employs 1,371 full-time employees. is a China-based company principally engaged in research and development, manufacture and sale of pharmaceuticals. The Company’s products are targeted for the treatment of influenza, cardio cerebrovascular diseases, rheumatoid bone diseases and in the areas of oncology, antifungal, antipyretic and gynaecology. The firm's main products include cantharidin sodium vitamin B6 injection, cantharidin sodium injection and other Chinese patent drug products. The firm distributes its products in domestic market.

Show more
Loading
600613
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Feng Bin
GM & Director
No Bio Available
Mr. Zhimian Chen
CFO & Director
No Bio Available
Xiajuan Wang
Accounting Supervisor
No Bio Available

Contacts

Address
SHANGHAI
Shanghai
Room 613, Changfa Tower, No. 128, Weihai Road
Contacts
+862153750009
www.gzsq.com